alexa Adverse Reactions Associated with Antiretroviral Regimens in Adult Patients of a University Teaching Hospital HIV Program in Zaria, Northern Nigeria: An Observational Cohort Study
ISSN: 1948-5964

Journal of Antivirals & Antiretrovirals
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Adverse Reactions Associated with Antiretroviral Regimens in Adult Patients of a University Teaching Hospital HIV Program in Zaria, Northern Nigeria: An Observational Cohort Study

Obiako O Reginald1,4*, Muktar M Haruna2,4, Garko B Sani1,4, Tobi-Ajayi Eric1,4, Olayinka T Adebola3,4, Iyanda Mathew4, Irohibe Chigozie4, Umar Bilkisu5 and Abdu-AguyeIbrahim1

1Department of Medicine, Clinical Pharmacology unit, Ahmadu Bello University, Nigeria

2Hematology & Blood Transfusion, Ahmadu Bello University, Nigeria

3Medical microbiology, Ahmadu Bello University, Nigeria

4APIN/HARVARDPEPFAR HIV Center, Ahmadu Bello University, Nigeria

5Pharmacy, Ahmadu Bello University Teaching Hospital (ABUTH) Shika Zaria, Nigeria

*Corresponding Author:
Obiako O Reginald
Department of Medicine
Clinical Pharmacology unit
Ahmadu Bello University
Zaria, Nigeria
E-mail: [email protected]

Received Date: November 16, 2011; Accepted Date: January 12, 2012; Published Date: January 14, 2012

Citation: Obiako OR, Muktar HM, Garko SB, Ajayi-Tobi E, Olayinka AT, et al. (2012) Adverse Reactions Associated with Antiretroviral Regimens in Adult Patients of a University Teaching Hospital HIV Program in Zaria, Northern Nigeria: An Observational Cohort Study. J Antivir Antiretrovir 4: 006-013. doi:10.4172/ jaa.1000039

Copyright: © 2012 Obiako OR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Background: Highly active antiretroviral therapy (HAART) has reduced the morbidity associated with HIV infection, and prolonged the lifespan of HIV/AIDS patients, but reports of adverse reactions associated with the antiretroviral drugs exist in the literature. The aim of this research was to determine the frequency and pattern of adverse drug reactions (ADRs) in HAART-experienced patients in our facility from January 2000 to December 2009.
Method: Patients on HAART who had a defined temporal relationship between an adverse or noxious reaction and the administration of the drugs at doses normally used in man for the treatment of HIV disease were studied. Patients who developed adverse reactions to non- antiretroviral drugs were excluded.
Result: of 3641 patients, 380 (10.4%) comprising 289 females (76.1 %) and 91 males (23.9%) of respective mean ages, 35.1 ± 7.4 and 43.2 ± 5.9 years, and respective median CD4+ cell counts, 256/ μL and 124/ μL, had various forms of ADRs. Zidovudine/lamivudine/nevirapine (43.2%), stavudine/lamivudine/nevirapine (26.3%), zidovudine/lamivudine+efavirenz (12.4%), truvada+ nevirapine (9.5%), zidovudine + truvada + ritonavir-boosted lopinavir (8.2%) and truvada/efavirenz (0.5%) were responsible. Mean onset of ADR was 34 days, and there was a female predisposition. The common ADRs were: nausea/hypersalivation/ vomiting (124, 34%), skin rash (100, 26.3%), Steven-Johnson syndrome (27, 7.1%) and anemia (27, 7.1%). Significant risk factors were: baseline CD4+ cell counts > 250/μL, on –therapy CD4+ cell counts > 250/μL, female gender, and type of regimen.
Conclusion: Current antiretroviral regimens are associated with various forms of ADRs, thus the need to strengthen pharmacovigilance and proper education of patients on the side effects and possible adverse reactions of ARV regimens.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords